A
Aldeyra Therapeutics (ALDX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aldeyra Therapeutics (ALDX)
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more
- USD3.96
- USD4.29
- USD3.96
- USD11.97
- 28.40%
- --
- 601.66k
- 234M
- 1.42
- -58.30%
Stock News
4 hours ago
Mirror publisher suffers hit as Facebook downgrades news articles
Yahoo
4 hours ago
Whether Wall Street garden leaves survive noncompete ban is an 'open question'
Yahoo
4 hours ago
AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Yahoo
5 hours ago
The top pharmaceutical companies by R&D expenditure
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
